111 related articles for article (PubMed ID: 8220893)
1. Functional evidence for multiple receptor activation by kappa-ligands in the inhibition of spinal nociceptive reflexes in the rat.
Herrero JF; Headley PM
Br J Pharmacol; 1993 Sep; 110(1):303-9. PubMed ID: 8220893
[TBL] [Abstract][Full Text] [Related]
2. The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.
Herrero JF; Headley PM
Br J Pharmacol; 1991 Sep; 104(1):166-70. PubMed ID: 1664760
[TBL] [Abstract][Full Text] [Related]
3. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
Parsons CG; West DC; Headley PM
Br J Pharmacol; 1989 Oct; 98(2):533-43. PubMed ID: 2555012
[TBL] [Abstract][Full Text] [Related]
4. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
Parsons CG; West DC; Headley PM
NIDA Res Monogr; 1986; 75():461-4. PubMed ID: 2828992
[TBL] [Abstract][Full Text] [Related]
5. On the selectivity of intravenous mu- and kappa-opioids between nociceptive and non-nociceptive reflexes in the spinalized rat.
Parsons CG; Headley PM
Br J Pharmacol; 1989 Oct; 98(2):544-51. PubMed ID: 2555013
[TBL] [Abstract][Full Text] [Related]
6. Stimulus intensity and the comparative efficacy of mu- and kappa-opioid agonists on nociceptive spinal reflexes in the rat.
Thorn SA; Herrero JF; Headley PM
Brain Res; 1994 Nov; 663(2):352-6. PubMed ID: 7874523
[TBL] [Abstract][Full Text] [Related]
7. Effects of intravenous mu and kappa opioid receptor agonists on sensory responses of convergent neurones in the dorsal horn of spinalized rats.
Dong XW; Parsons CG; Headley PM
Br J Pharmacol; 1991 May; 103(1):1230-6. PubMed ID: 1652344
[TBL] [Abstract][Full Text] [Related]
8. Spinal antinociceptive actions of mu- and kappa-opioids: the importance of stimulus intensity in determining 'selectivity' between reflexes to different modalities of noxious stimulus.
Parsons CG; Headley PM
Br J Pharmacol; 1989 Oct; 98(2):523-32. PubMed ID: 2555011
[TBL] [Abstract][Full Text] [Related]
9. Calcium channel modulators modify K opioid-induced inhibition of C-fiber-evoked spinal reflexes in rat.
Hernández A; Contreras E; Paeile C; Pérez H; Pelissier T; Quijada L; Soto-Moyano R
Int J Neurosci; 1993 Oct; 72(3-4):167-74. PubMed ID: 7511132
[TBL] [Abstract][Full Text] [Related]
10. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
[TBL] [Abstract][Full Text] [Related]
11. Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse.
Horan PJ; de Costa BR; Rice K; Haaseth RC; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1993 Aug; 266(2):926-33. PubMed ID: 8394923
[TBL] [Abstract][Full Text] [Related]
12. [The effect of mu-, delta- and kappa-opiate receptor agonists on the bioelectrical activity of the viscerosomatic convergent neurons in the posterior horn of the spinal cord].
Kasparov SA
Eksp Klin Farmakol; 1993; 56(1):13-6. PubMed ID: 8391888
[TBL] [Abstract][Full Text] [Related]
13. Spinal analgesic actions of kappa receptor agonists, U-50488H and spiradoline (U-62066).
Piercey MF; Einspahr FJ
J Pharmacol Exp Ther; 1989 Oct; 251(1):267-71. PubMed ID: 2552077
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
Rahmani NH; Gulati A; Bhargava HN
Pharmacology; 1991; 43(3):156-62. PubMed ID: 1663623
[TBL] [Abstract][Full Text] [Related]
15. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
Scheurer U; Wenger F; Caliezi A; Drack E; Varga L; Halter F
J Pharmacol Exp Ther; 1990 Mar; 252(3):1324-30. PubMed ID: 1969475
[TBL] [Abstract][Full Text] [Related]
16. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
17. Effects of spinal kappa-opioid receptor agonists on the responsiveness of nociceptive superficial dorsal horn neurons.
Hylden JLK; Nahin RL; Traub RJ; Dubner R
Pain; 1991 Feb; 44(2):187-193. PubMed ID: 1675783
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic evaluation of pressor and visceromotor reflex responses to bladder distension.
Su X; Riedel ES; Leon LA; Laping NJ
Neurourol Urodyn; 2008; 27(3):249-53. PubMed ID: 17598175
[TBL] [Abstract][Full Text] [Related]
19. Modulation of thymidine incorporation by kappa-opioid ligands in rat spinal cord-dorsal root ganglion co-cultures.
Barg J; Nah SY; Levy R; Saya D; Vogel Z
Brain Res; 1993 Nov; 629(1):109-14. PubMed ID: 8287265
[TBL] [Abstract][Full Text] [Related]
20. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices.
Suarez-Roca H; Maixner W
J Pharmacol Exp Ther; 1993 Feb; 264(2):648-53. PubMed ID: 7679733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
